Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

197.55 +1.18 (+0.60%)
Official Closing Price Updated: 7:00 PM EDT, Aug 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,726,919
Open 197.25
Bid (Size) 197.00 (1)
Ask (Size) 198.00 (1)
Prev. Close 196.37
Today's Range 196.23 - 197.98
52wk Range 135.85 - 197.98
Shares Outstanding N/A
Dividend Yield 3.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
Analysts expect Novo Nordisk's Ozempic and other major drugs to be included in 2027 Medicare price negotiations. Despite concerns, experts predict limited financial impact on companies like Pfizer,... 
Via Benzinga
Key Takeaways From AbbVie Analyst Ratings
Via Benzinga

Performance

YTD
+23.61%
+23.61%
1 Month
+8.44%
+8.44%
3 Month
+27.17%
+27.17%
6 Month
+10.48%
+10.48%
1 Year
+34.67%
+34.67%

More News

Read More
How To Build A Dividend Growth Portfolio In An Overpriced Market
Via Talk Markets
Topics Stocks
Exposures US Equities
Unpacking the Latest Options Trading Trends in AbbVie
Via Benzinga
Biotech Bull Market: 3 Ways To Play It
Via Talk Markets
Topics Economy
Exposures Interest Rates
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
Via Benzinga
Decoding AbbVie's Options Activity: What's the Big Picture?
Via Benzinga
Botox Innovator Revance Therapeutics Goes Private In Over $900M Deal
Via Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
Via Benzinga
3 High-Yield Stocks to Buy Now That Have Increased Their Dividends for 25 Years or More
Via The Motley Fool
These 3 Healthcare Companies Had the Top-Selling Drugs Last Year
Via The Motley Fool
3 High-Yielding Dividend Growth Stocks That Retirees Can Rely On for Recurring Income
Via The Motley Fool
Lock in Gains: 3 Dividend Stocks Poised to Boost Payouts Soon
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
The 3 Best Stocks to Buy to Survive Another S&P 500 Crash
Via InvestorPlace
Topics Economy Stocks
Exposures Economy US Equities
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
Via Benzinga
3 Stocks Retirees Should Absolutely Love
Via The Motley Fool
As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032
Via FinancialNewsMedia
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
Via Talk Markets
Topics Stocks
Exposures US Equities
Warren Buffett's Approach To Investing In Election Years
Via Benzinga
Elliott Wave Technical Analysis: AbbVie Inc.
Via Talk Markets
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
Via PressReach
Exposures Product Safety
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
Via Benzinga
Large Cap Biopharma And Healthcare, A Port In A Storm
Via Talk Markets
Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever.
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.